The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

She’s a pediatrician, an asthma researcher at Harvard Medical School, and the mom of a 14-year-old who’s had asthma since she was a toddler, so Ann Chen Wu, M.D., knows how to look at asthma from ...

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...

The MHRA has approved depemokimab as an add on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

Sandoz Group Ltd ($SDZXF) announced an update on their ongoing clinical study. Study Overview: Sandoz Group Ltd is conducting a clinical study ...

More than 24 million Americans have been diagnosed with asthma, and 10 percent of them have a tough time controlling it, even with treatment. But a new form of therapy -- known as biologic -- is ...

Asthma is a lifelong condition with no cure, but there are many ways to manage your symptoms. Short-acting medications help you breathe when you’re having an attack. Long-term drugs work to keep ...

Maryland lawmakers introduce the Affordable Inhalers and Nebulizers Act to reduce the cost of inhalers and expand Medicare ...

Chinese scientists have developed a groundbreaking cell therapy that could provide long-term relief for asthma patients with just a single shot. This new treatment, which has shown promising results ...

Tony Cook runs up to 7 miles a day, but until recently, his severe asthma made it too painful for him to work out for very long. “It feels like a coil is just tightening around your lungs and you ...

Six million American kids now have asthma—twice as many as 20 years ago. This mysterious epidemic panics parents, confounds doctors, and sends nearly 700,000 kids to the ER each year with I can't ...